0001579587-24-000013.txt : 20240611 0001579587-24-000013.hdr.sgml : 20240611 20240611165143 ACCESSION NUMBER: 0001579587-24-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240607 FILED AS OF DATE: 20240611 DATE AS OF CHANGE: 20240611 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marken James G. CENTRAL INDEX KEY: 0001579587 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 241036452 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST STREET 2: C/O BIOSANTE PHARMACEUTICALS, INC. CITY: BAUDETTE STATE: MN ZIP: 56623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 wk-form4_1718139096.xml FORM 4 X0508 4 2024-06-07 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001579587 Marken James G. C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 0 1 0 0 SVP OPS & PROD DEV 0 Common Stock 2024-06-07 4 M 0 7250 49.51 A 123616 D Common Stock 2024-06-07 4 M 0 5300 57.06 A 128916 D Common Stock 2024-06-07 4 F 0 11087 67.70 D 117829 D Stock Option (right to buy) 49.51 2024-06-07 4 M 0 7250 49.51 D 2027-03-30 Common Stock 7250 0 D Stock Option (right to buy) 57.06 2024-06-07 4 M 0 5300 57.06 D 2028-04-05 Common Stock 5300 0 D The number of shares beneficially owned by the reporting person is amended in this Form 4 to correct an administrative error in a Form 4 filed on March 9, 2023, which misreported that 1,951 shares were withheld on March 7, 2023 to cover taxes on a vesting of shares on that date, when 1,591 shares were withheld. In correcting this administrative error, the number of shares beneficially owned by the reporting person reflects an increase of 360 shares. The shares were sold in multiple trades at prices ranging from $67.64 to $68.10. The price reported above reflects the weighted average sales price. 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. 25% of the total options vested on each of April 6, 2019, April 6, 2020, April 6, 2021, and April 6, 2022. /s/ James G. Marken, by attorney-in-fact Meredith W. Cook 2024-06-11